The DOI matches its Crossref record, with a small difference in title or year; 251 of the 252 references it cites were found in a registry or an index.
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Open accessAbstract
Hypertrophic cardiomyopathy (HCM) is a genetic disorder that is characterized by left ventricular hypertrophy unexplained by secondary causes and a nondilated left ventricle with preserved or increased ejection fraction. It is commonly asymmetrical with the most severe hypertrophy involving the basal interventricular septum. Left ventricular outflow tract obstruction is present at rest in about one third of the patients and can be provoked in another third. The histological features of HCM include myocyte hypertrophy and disarray, as well as interstitial fibrosis. The hypertrophy is also frequently associated with left ventricular diastolic dysfunction. In the majority of patients, HCM has a relatively benign course. However, HCM is also an important cause of sudden cardiac death, particularly in adolescents and young adults. Nonsustained ventricular tachycardia, syncope, a family history of sudden cardiac death, and severe cardiac hypertrophy are major risk factors for sudden cardiac death. This complication can usually be averted by implantation of a cardioverter-defibrillator in appropriate high-risk patients. Atrial fibrillation is also a common complication and is not well tolerated. Mutations in over a dozen genes encoding sarcomere-associated proteins cause HCM. MYH7 and MYBPC3 , encoding β-myosin heavy chain and myosin-binding protein C, respectively, are the 2 most common genes involved, together accounting for ≈50% of the HCM families. In ≈40% of HCM patients, the causal genes remain to be identified. Mutations in genes responsible for storage diseases also cause a phenotype resembling HCM (genocopy or phenocopy). The routine applications of genetic testing and preclinical identification of family members represents an important advance. The genetic discoveries have enhanced understanding of the molecular pathogenesis of HCM and have stimulated efforts designed to identify new therapeutic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This clinical variability can, in part, be explained by the influence of modifiable cardiometabolic risk factors, such as obesity, diabetes, and hypertension [6].”
From Association of GLP-1 receptor agonist use with cardiovascular outcomes in patients with non-obstructive hypertrophic cardiomyopathy (2026) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“Hypertrophic cardiomyopathy (HCM) is characterized by cardiac hypertrophy, a non-dilated left ventricle (LV), and a normal or increased EF.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [52]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults
Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T., & Bild, D. E. (1995) · Circulation · doi:10.1161/01.cir.92.4.785 · Cited by 2,274
Sudden Deaths in Young Competitive Athletes
Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009) · Circulation · doi:10.1161/circulationaha.108.804617 · Cited by 2,099
Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles
Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
Semsarian, C., Ingles, J., Maron, M. S., & Maron, B. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.019 · Cited by 1,405
Geisterfer-Lowrance, A. A. T., Kass, S., Tanigawa, G., Vosberg, H.-P., McKenna, W., Seidman, C. E., & Seidman, J. G. (1990) · Cell · doi:10.1016/0092-8674(90)90274-i · Cited by 1,380
Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,276
O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht439 · Cited by 1,251
Research works printed but not linked: 2
- 10.1161/01.CIR.104.3.317 · DOI
- BROCK R. Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis). Guys Hosp Rep. 1959;108:126–143.
Cited by
Sorted by citations
Items 401–500 of 1,001
Hilderink, S., Schuldt, M., Goebel, M., Jansen, V. J., Manders, E., Moorman, S., Dorsch, L. M., van Steenbeek, F. G., van der Velden, J., & Kuster, D. W. D. (2023) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2023.10.008 · Cited by 14
Sawan, M. A., Prabakaran, S., D'Souza, M. S., Behbahani‐Nejad, O., Gold, M. E., Williams, B. R., & Bilen, O. (2024) · Clinical Cardiology · doi:10.1002/clc.24207 · Cited by 13
Retrofitting the Heart: Explaining the Enigmatic Septal Thickening in Hypertrophic Cardiomyopathy
Federspiel, J. M., Reil, J., Xu, A., Scholtz, S., Batzner, A., Maack, C., & Sequeira, V. (2024) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.011435 · Cited by 13
Williams, N., Marion, R., McDonald, T. V., Wang, D., Zhou, B., Eng, L. S., Um, S. Y., Lin, Y. L., Ruiter, K., Rojas, L., et al. (2018) · Cardiovascular Pathology · doi:10.1016/j.carpath.2018.09.001 · Cited by 13
Kaźmierczak, K., Liang, J., Yuan, C.-C., Yadav, S. K., Sitbon, Y. H., Walz, K., Ma, W., Irving, T. C., Cheah, J. X., Gomes, A. V., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201801402r · Cited by 13
Cardiomyopathies in children: classification, diagnosis and treatment
Angelis, G. D., Bobbo, M., Paldino, A., Mottolese, B. D., Altinier, A., Ferro, M. D., Merlo, M., & Sinagra, G. (2020) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000755 · Cited by 13
Attenuation of Cardiomyocyte Hypertrophy via Depletion Myh7 using CASAAV
Yue, P., Xia, S., Wu, G., Liu, L., Zhou, K., Liao, H., Li, J., Zheng, X., Guo, Y., Hua, Y., et al. (2020) · Cardiovascular Toxicology · doi:10.1007/s12012-020-09617-y · Cited by 13
The Immune and Inflammatory Basis of Acquired Pediatric Cardiac Disease
Jui, E., Singampalli, K. L., Shani, K., Ning, Y. Y., Connell, J. P., Birla, R. K., Bollyky, P. L., Caldarone, C. A., Keswani, S. G., & Grande-Allen, K. J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.701224 · Cited by 13
Septal Ablation Versus Surgical Myomectomy for Hypertrophic Obstructive Cardiomyopathy
Pelliccia, F., Seggewiß, H., Cecchi, F., Calabrò, P., Limongelli, G., Alfieri, O., Ferrazzi, P., Yacoub, M. H., & Olivotto, I. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01600-5 · Cited by 13
García‐Padilla, C., Domínguez, J. N., Lodde, V., Munk, R., Abdelmohsen, K., Gorospe, M., Jiménez-Sábado, V., Ginel, A., Hove‐Madsen, L., Aránega, A. E., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100844rr · Cited by 13
Shen, Y., Gao, Y., Shi, J., Huang, Z., Dai, R., Fu, Y., Zhou, Y., Kong, W., & Cui, Q. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.08.002 · Cited by 13
Genetic analysis of patients with hypertrophic cardiomyopathy
Dementyeva, E. V., Vyatkin, Y. V., Kretov, E. I., Elisaphenko, E. A., Medvedev, S. P., & Zakian, S. M. (2020) · Genes and Cells · doi:10.23868/202011011 · Cited by 13
Volume-outcome relationship in septal myectomy for hypertrophic obstructive cardiomyopathy
Hadaya, J. E., Verma, A., Sanaiha, Y., Shemin, R. J., & Benharash, P. (2023) · Surgery · doi:10.1016/j.surg.2023.04.028 · Cited by 14
Small Molecule Effectors of Myosin Function
Manstein, D. J., & Preller, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38062-5_5 · Cited by 13
Pecorari, I., Mestroni, L., & Sbaizero, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165865 · Cited by 13
Preventative therapeutic approaches for hypertrophic cardiomyopathy
Solomon, T., Filipovska, A., Hool, L. C., & Viola, H. M. (2020) · The Journal of Physiology · doi:10.1113/jp279410 · Cited by 13
Conduction system pacing following septal myectomy: Insights into site of conduction block
Zheng, R., Dong, Y., Wu, S., Su, L., Zhao, D., Chen, X., Cai, B., Fang, X., Vijayaraman, P., & Huang, W. (2022) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15362 · Cited by 13
Kissopoulou, A., Trinks, C., Gréen, A., Karlsson, J., Jonasson, J., & Gunnarsson, C. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12288 · Cited by 13
Vo, Q. D., Nakamura, K., Saito, Y., Akagi, S., Miyoshi, T., & Yuasa, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26114984 · Cited by 13
Protective effects of flavonoids against silver nanoparticles-induced toxicity
Santos, I., Sousa, A., Vale, A., Carvalho, F. D., Fernandes, E. G. R., & Freitas, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04068-2 · Cited by 13
Glavaški, M., & Velicki, L. (2021) · Life · doi:10.3390/life11080785 · Cited by 12
Spectrum of Rare and Common Genetic Variants in Arrhythmogenic Cardiomyopathy Patients
Lippi, M., Chiesa, M., Ascione, C., Pedrazzini, M., Mushtaq, S., Rovina, D., Riggio, D., Blasio, A. M. D., Biondi, M. L., Pompilio, G., et al. (2022) · Biomolecules · doi:10.3390/biom12081043 · Cited by 12
Sarhan, N. M., Warda, A. E. A., Alsahali, S. M., & Alanazi, A. S. (2023) · Pharmaceuticals · doi:10.3390/ph16020262 · Cited by 12
Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine
Ogi, D. A., & Jin, S. (2023) · Cells · doi:10.3390/cells12101442 · Cited by 13
Kosuge, H., Hachiya, S., Fujita, Y., Hida, S., & Chikamori, T. (2023) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-023-00966-5 · Cited by 12
Obstructive Hypertrophic Cardiomyopathy: A Review of New Therapies
Mehra, N. S., Ali, A. H., & Desai, M. Y. (2023) · Future Cardiology · doi:10.2217/fca-2023-0056 · Cited by 12
A multiscale finite element model of left ventricular mechanics incorporating baroreflex regulation
Sharifi, H., Lee, L. C., Campbell, K. S., & Wenk, J. F. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107690 · Cited by 12
Amesz, J. H., Langmuur, S. J. J., Zhang, L., Manintveld, O. C., Schinkel, A. F. L., de Jong, P. L., de Groot, N. M. S., & Taverne, Y. J. H. J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116036 · Cited by 12
Hypertrophic cardiomyopathy in MYBPC3 carriers in aging
Ananthamohan, K., Stelzer, J. E., & Sadayappan, S. (2024) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.29 · Cited by 13
Spaapen, T. O. M., Bohte, A. E., Slieker, M. G., & Grotenhuis, H. B. (2024) · British Journal of Radiology · doi:10.1093/bjr/tqae033 · Cited by 12
Genetic Markers of Cardiovascular Disease
Varghese, T. P. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102588 · Cited by 12
Scolari, F. L., Brahmbhatt, D. H., Abelson, S., Lee, D. Z. J., Kim, R. H., Pedarzadeh, A., Sakhnini, A., Adler, A., Chan, R. H. M., Dick, J. E., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3408 · Cited by 13
An optimization framework to personalize passive cardiac mechanics
Shi, L. T., Chen, I. Y., Takayama, H., & Vedula, V. (2024) · Computer Methods in Applied Mechanics and Engineering · doi:10.1016/j.cma.2024.117401 · Cited by 12
Schoonvelde, S. A. C., Alexandridis, G. M., Price, L. B., Schinkel, A. F. L., Hirsch, A., Zwetsloot, P.-P. M., Kammeraad, J. A. E., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132951 · Cited by 11
Exercise stress testing: A valuable tool to predict risk and prognosis
Edelson, J. B., Burstein, D. S., Paridon, S. M., & Stephens, P. (2019) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2019.101130 · Cited by 13
Rajiah, P. S., Kirsch, J., Bolen, M. A., Batlle, J. C., Brown, R. K. J., François, C. J., Galizia, M. S., Hanneman, K. A., Inácio, J. R., Johri, A. M., et al. (2021) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2021.01.019 · Cited by 12
Cardiomyocyte Dysfunction in Inherited Cardiomyopathies
Hassoun, R., Budde, H., Mügge, A., & Hamdani, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011154 · Cited by 13
Gene and metabolite expression dependence on body mass index in human myocardium
Adebayo, A. S., Roman, M., Zakkar, M., Yusoff, S., Gulston, M. K., Joel‐David, L., Anthony, B., Lai, F. Y., Murgia, A., Eagle‐Hemming, B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05562-8 · Cited by 11
Butzner, M., LESLIE, D. L., Cuffee, Y., Hollenbeak, C. S., Sciamanna, C., & Abraham, T. P. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058151 · Cited by 12
Torrado, M., Maneiro, E., Lamounier, A., Fernández‐Burriel, M., Giralt, S. S., Martínez-Carapeto, A., Cazón, L., Santiago, E., Ochoa, J. P., McKenna, W. J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11159-y · Cited by 12
Parijat, P., Ponnam, S., Attili, S., Campbell, K. S., El‐Mezgueldi, M., Pfuhl, M., & Kampourakis, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-32476-w · Cited by 14
Garmany, R., Bos, J. M., Dasari, S., Johnson, K. L., Tester, D. J., Giudicessi, J. R., dos Remedios, C. G., Maleszewski, J. J., Ommen, S. R., Dearani, J. A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40795-1 · Cited by 12
Increased Chamber Resting Tone Is a Key Determinant of Left Ventricular Diastolic Dysfunction
Tamargo, M., Martínez‐Legazpi, P., Espinosa, M. Á., Lyon, A., Méndez, I., Gutiérrez, E., Fernández, A. I., Prieto-Arévalo, R., González‐Mansilla, A., Arts, T. G. J., et al. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.010673 · Cited by 12
Screening Pediatric Patients in New-Onset Syncope (SPINS) Study
Gupta, A., Menoch, M., Levasseur, K. A., & Gonzalez, I. E. (2019) · Clinical Pediatrics · doi:10.1177/0009922819885660 · Cited by 12
RNA‐sequencing‐based transcriptome analysis of cantharidin‐induced myocardial injury
Zhang, Y., Liu, L., & Ren, L. (2020) · Journal of Applied Toxicology · doi:10.1002/jat.4000 · Cited by 12
Stochastic allelic expression as trigger for contractile imbalance in hypertrophic cardiomyopathy
Montag, J., & Kraft, T. (2020) · Biophysical Reviews · doi:10.1007/s12551-020-00719-z · Cited by 12
Campbell, K. S., Chrisman, B., & Campbell, S. G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01043 · Cited by 12
Wang, Z., Chan, H., Gambarotta, G., Smith, N. J., Purdue, B. W., Pennisi, D. J., Porrello, E. R., O’Brien, S. L., Reichelt, M. E., Thomas, W. G., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30487 · Cited by 12
ELAC2/RNaseZ-linked cardiac hypertrophy in Drosophila melanogaster
Migunova, E., Theophilopoulos, J., Mercadante, M. N., Men, J., Zhou, C., & Dubrovsky, E. B. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048931 · Cited by 12
Guo, N., Zheng, D., Sun, J., Lv, J., Wang, S., Fang, Y., Zhao, Z., Zeng, S., Guo, Q., Tong, J., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.791501 · Cited by 11
Regression from pathological hypertrophy in mice is sexually dimorphic and stimulus specific
Muehleman, D., Crocini, C., Swearingen, A. R., Ozeroff, C. D., & Leinwand, L. A. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00644.2021 · Cited by 12
Advances in hypertrophic cardiomyopathy: What the cardiologist needs to know
Toste, A. (2022) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.05.015 · Cited by 12
Mutation of the MYL3 gene in a patient with mid-ventricular obstructive hypertrophic cardiomyopathy
Mavilakandy, A. K., & Ahamed, H. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-244573 · Cited by 11
Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
Burkart, V., Kowalski, K., Aldag-Niebling, D., Beck, J., Frick, D. A., Holler, T., Radocaj, A., Piep, B., Zeug, A., Hilfiker‐Kleiner, D., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.987889 · Cited by 11
Miyashita, S., Akita, K., Zhao, Y., Hasegawa, K., Maurer, M. S., Weiner, S. D., Reilly, M. P., Takayama, H., & Shimada, Y. J. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14414 · Cited by 11
Advances in Multi-Modality Imaging in Hypertrophic Cardiomyopathy
Goldie, F. C., Lee, M. M. Y., COATS, C. J., & Nordin, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030842 · Cited by 11
Zhang, Y., Zhao, J., Jin, Q., & Zhuang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052816 · Cited by 11
Huang, H., Verma, J., Mok, V., Bharadwaj, H. R., Alrawashdeh, M. M., Aratikatla, A., Sudan, S., Talukder, S., Habaka, M., Tse, G., et al. (2024) · Global Medical Genetics · doi:10.1055/s-0044-1779469 · Cited by 15
Kalinski, J. K., Xu, B., Boyd, R. L., Tasseff, N., Rutkowski, K., Ospina, S., Smedira, N., Thamilarasan, M., Popović, Z., & Desai, M. Y. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00667-z · Cited by 13
MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids
Desai, D. A., Song, T., Singh, R. R., Baby, A., McNamara, J. W., Green, L. C., Nabavizadeh, P., Ericksen, M. B., Bazrafshan, S., Natesan, S., et al. (2024) · Cells · doi:10.3390/cells13221913 · Cited by 10
The Role of Signalling Pathways in Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Skórka, P., Piotrowski, J., Bakinowska, E., Kiełbowski, K., & Pawlik, A. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm27152 · Cited by 12
Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
Silva, J., & Martins, P. A. D. C. (2022) · Cells · doi:10.3390/cells11111805 · Cited by 11
Hendrix, C. L. F., van den Heuvel, F. M. A., Rodwell, L., Timmermans, J., Nijveldt, R., Janssen, M. C. H., & Saris, C. G. J. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.05.004 · Cited by 11
Aguiar, T., & Martins, E. (2022) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.09.013 · Cited by 11
Wang, K., Zhou, M., Zhang, Y., Du, Y., Li, P., Guan, C., & Huang, Z. (2022) · International Journal of Cardiology · doi:10.1016/j.ijcard.2022.09.070 · Cited by 11
Zhao, W., Wu, T., Zhang, J., & Dong, Z. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/7153491 · Cited by 11
RetractedCadena-Ullauri, S., Guevara‐Ramírez, P., Ruiz‐Pozo, V. A., Tamayo‐Trujillo, R., Paz‐Cruz, E., Insuasty, T. S., Doménech, N., Ibarra-Rodríguez, A. A., & Zambrano, A. K. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1037370 · Cited by 11
Emerging Themes in Genetics of Hypertrophic Cardiomyopathy: Current Status and Clinical Application
García-Hernández, S., Romero, L. D. L. H., Ochoa, J. P., & McKenna, W. J. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.01.011 · Cited by 11
Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options
Stătescu, C., Enachi, Ș., Ureche, C., Tapoi, L. C., Anghel, L., Șalaru, D. L., Pleșoianu, C. E., Bostan, M., Marcu, D. T. M., Balasanian, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137218 · Cited by 11
Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells
Pávez, M., & Cyganek, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.800529 · Cited by 12
Modern genomic techniques in the identification of genetic causes of cardiomyopathy
Spracklen, T. F., Keavney, B. D., Laing, N., Ntusi, N., & Shaboodien, G. (2022) · Heart · doi:10.1136/heartjnl-2021-320424 · Cited by 10
Specific microRNAs and heart failure: time for the next step toward application?
Šigutová, R., Evin, L., Stejskal, D., Ploticová, V., & Švagera, Z. (2022) · Biomedical Papers · doi:10.5507/bp.2022.028 · Cited by 11
Leisure-time and competitive sport participation: a changing paradigm for HCM patients
Pelliccia, A., Day, S. M., & Olivotto, I. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad011 · Cited by 11
Chiang, Y. P., Shimada, Y. J., Ginns, J. N., Weiner, S. D., & Takayama, H. (2018) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-018-0895-0 · Cited by 11
Hypertrophic Cardiomyopathy Phenocopies: Classification, Key Features, and Differential Diagnosis
Teresi, L., Trimarchi, G., Licordari, R., Restelli, D., Taverna, G., Liotta, P., Micari, A., Smecca, I. M., Dendramis, G., Turturiello, D., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13123062 · Cited by 10
Heart-on-a-chip and vasculature-on-a-chip platforms as models of cardiovascular disease
Khosravi, R., & Radisic, M. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01255-1 · Cited by 12
Gatterer, C., Beitzke, D., Graf, S., Lenz, M. W., Sunder–Plassmann, G., Mann, C., Ponleitner, M., Manka, R., Fritschi, D., Krayenbuehl, P., et al. (2023) · Life · doi:10.3390/life13051213 · Cited by 10
Extracellular vesicles in cardiomyopathies: A narrative review
Rizzuto, A. S., Faggiano, A., Macchi, C., Carugo, S., Perrino, C., & Ruscica, M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23765 · Cited by 10
Zach, D. K., Schwegel, N., Santner, V., Winkelbauer, L., Höller, V., Kolesnik, E., Gollmer, J., Seggewiß, H., Batzner, A., Perl, S., et al. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131661 · Cited by 10
Wu, W., Liu, R., Guo, S., Song, W., Hua, Y., Hong, M., Zheng, J., Zhu, K. Y., Cao, P., & Duan, J. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118193 · Cited by 10
Mukhopadhyay, S., Dixit, P., Khanom, N., Sanghera, G., & McGurk, K. A. (2024) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-024-10520-y · Cited by 13
Wang, Y., & Yin, L. (2024) · Exploration of Cardiology · doi:10.37349/ec.2024.00025 · Cited by 10
Zou, C., Zou, H.-X., Jiang, Y., Lai, S., & Liu, J. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.09.022 · Cited by 11
Banthiya, S., Check, L., & Atkins, J. (2024) · US Cardiology Review · doi:10.15420/usc.2023.21 · Cited by 10
Badran, H. M., Helmy, J. A., Ahmed, N. F., & Yacoub, M. H. (2024) · Echocardiography · doi:10.1111/echo.70048 · Cited by 10
Kwak, S., Kim, J., Park, C. S., Lee, H., Park, J., Lee, S., Kim, Y.-J., Kim, H., Lee, S., & Wang, A. (2025) · Korean Circulation Journal · doi:10.4070/kcj.2024.0213 · Cited by 10
Yu, M., Song, M. O., Zhang, M., Chen, S., Ni, B., Li, X., Lei, W., Shen, Z., Fan, Y., Zhang, J. J., et al. (2025) · Cell Proliferation · doi:10.1111/cpr.70002 · Cited by 10
Clinical-Diagnostic and Therapeutic Advances in Feline Hypertrophic Cardiomyopathy
de Sousa, F. G., Mendes, A. C., de Carvalho, L., & Beier, S. L. (2025) · Veterinary Sciences · doi:10.3390/vetsci12030289 · Cited by 10
Choi, E., Chung, H., & Lee, K. (2025) · Journal of Cardiovascular Imaging · doi:10.1186/s44348-025-00055-4 · Cited by 11
Steding‐Ehrenborg, K., Hedström, E., Carlsson, M., Maksuti, E., Broomé, M., Ugander, M., Magnusson, M., Smith, J. G., & Arheden, H. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00890.2020 · Cited by 11
Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
Filatova, E. V., Krylova, N. S., Vlasov, I. N., Maslova, M. S., Потешкина, Н. Г., Slominsky, P. A., & Shadrina, M. I. (2021) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1808 · Cited by 10
Identification of Hub Diagnostic Biomarkers and Candidate Therapeutic Drugs in Heart Failure
Guo, Y., Ning, B., Zhang, Q., Ma, J., Zhao, L., Lu, Q., & Zhang, D. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s349235 · Cited by 10
Wang, Z., Zheng, Y., Ruan, H., Li, L., Zhang, M., Duan, L., & He, S. (2023) · PeerJ · doi:10.7717/peerj.14614 · Cited by 10
Identification of circRNA-miRNA-mRNA regulatory network and its role in cardiac hypertrophy
Gong, K. Q., Yang, K., Xie, T., Luo, Y., Guo, H., Tan, Z., Chen, J., Wu, Q., Gong, Y., Wei, L., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279638 · Cited by 10
Zhao, Y. L., Li, C., Tang, D., Luo, Y., Xiang, C., Huang, L., Zhou, X., Fang, J., Wei, X., & Xia, L. (2023) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-023-00987-0 · Cited by 10
Gao, W., Guo, N., Yan, H., Zhao, S., Sun, Y., & Chen, Z. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-03748-8 · Cited by 10
Canciello, G., Lombardi, R., Borrelli, F., Ordine, L., Chen, S. N., Santoro, C., Frisso, G., Napoli, S., Polizzi, R., Cristiano, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158128 · Cited by 10
Epistasis regulates genetic control of cardiac hypertrophy
Wang, Q., Tang, T. M., Youlton, M., Weldy, C. S., Kenney, A., Ronen, O., Hughes, J. W., Chin, E. T., Sutton, S. C., Agarwal, A., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00656-8 · Cited by 13
Clinical and genetic backgrounds of hypertrophic cardiomyopathy with mid-ventricular obstruction
Inagaki, N., Hayashi, T., Takei, Y., Tanimoto, K., Chikamori, T., & Kimura, A. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0509-9 · Cited by 10
Follow-up and prognosis of HCM
Domínguez, F., Sanz‐Sánchez, J., García‐Pavía, P., & Zorio, E. (2018) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2018.33 · Cited by 10
Metadata
- Authors
- Marian, A. J., & Braunwald, E.
- Affiliations
- Brigham and Women's Hospital (US)
- From the Center for Cardiovascular Genetics, Institute of Molecular Medicine, Department of Medicine, University of Texas Health Sciences Center at Houston (A.J.M.); Texas Heart Institute, Houston (A.J.M.); and TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (E.B.).
- ORCID
- Marian, Ali J.
- Venue
- Circulation Research
- Published
- 2017-09-15
- Volume
- 121
- Issue
- 7
- Pages
- 749-770
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC5654557
- OpenAlex
- W2756203218
- Cited by
- 1,403
- References
- 252
- Citations by year
- 2026: 175 · 2025: 226 · 2024: 219 · 2023: 199 · 2022: 153 · 2021: 174 · 2020: 103 · 2019: 83 · 2018: 61 · 2017: 6
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL088498, R01HL132401)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- hypertrophic cardiomyopathy, left ventricular hypertrophy, left ventricular outflow tract obstruction, sudden cardiac death, non-sustained ventricular tachycardia, syncope, cardioverter-defibrillator implantation, atrial fibrillation, sarcomere gene mutations, MYH7, MYBPC3, genetic testing, phenocopy, storage diseases, left ventricular diastolic dysfunction, interstitial fibrosis, molecular pathogenesis
- MeSH terms
- Animals, Biopsy, Cardiomyopathy, Dilated, DNA Mutational Analysis, Genetic Markers, Humans, Mutation, Myocardium, Phenotype, Predictive Value of Tests, Prognosis, Risk Factors, Ventricular Function, Left, Risk Assessment, Genetic Predisposition to Disease, Molecular Diagnostic Techniques, Cardiac Imaging Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
